Related Experiment Video
Updated: Aug 17, 2026

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
US with contrast medium in the diagnosis of abdominal Castleman's disease
Gennaro Annunziata1, Pasquale Martino, Silvano Palazzo
1Dipartimento dell'Emergenza e dei Trapianti di Organi, Università di Bari, Italy.
Insights
Castleman's disease is a rare lymphoproliferative disorder. This review highlights imaging findings, suggesting ultrasound contrast media could aid diagnosis of abdominal Castleman's disease, potentially reducing reliance on CT and MRI.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Castleman's disease is a rare, heterogeneous lymphoproliferative disorder with uncertain etiology.
- Abdominal Castleman's disease is uncommon, with retroperitoneal, mesenteric, and pelvic sites reported.
- Diagnosis is often incidental, identified through imaging modalities like ultrasound (US), CT, and MRI.
Observation:
- Imaging characteristics of abdominal Castleman's disease were reviewed across 31 cases.
- Contrast enhancement patterns on CT and MRI varied based on lymph node size: homogeneous for <5 cm and dyshomogeneous for >5 cm.
- The current case demonstrated similar vascular enhancement behavior on US, CT, and MRI after contrast administration.
Findings:
- Abdominal Castleman's disease presents with diverse imaging findings.
- Specific contrast enhancement patterns on CT/MRI correlate with lymph node size.
- Ultrasound showed comparable vascular enhancement to CT/MRI in the observed case.
Implications:
- Further research into ultrasound contrast media is warranted for diagnosing abdominal Castleman's disease.
- Successful validation could reduce the need for CT and MRI in evaluating localized abdominal masses.
- This may lead to safer, more accessible diagnostic approaches for Castleman's disease.
Abstract:
Castleman's disease belongs to a heterogeneous group of rare lymphoproliferative disorders of uncertain cause. A literature review yielded 31 cases of Castleman's disease with an abdominal localization. Retroperitoneal, mesenteric and pelvic sites have been reported and the diagnosis was incidental in almost all cases and detected at US, CT scan or MRI and angiography. If the lymphadenopathy was less than 5 cm, centripetal, homogeneous contrast enhancement was apparent during CT scan or MRI, versus dyshomogeneous enhancement for a lymph node with a diameter above 5 cm. In our case, similar vascular behavior after administration of contrast medium was observed with ultrasound, CT scan or MRI. Further studies with ultrasound contrast media are needed to confirm this particular behavior in order to avoid the use of MRI and CT scans in cases of localized abdominal masses in the future.
Related Concept Videos
Radiological Investigation I: X-ray and CT
Imaging Studies III: Computed Tomography
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Imaging Studies for Cardiovascular System V: CT
